Repatha International Purchase Legalities: What You Need to Know Before You Order

What Does U.S. Law Actually Say About Importing Repatha?

The FDA's legal position is clear on paper: importing unapproved or foreign-labeled prescription drugs into the United States is prohibited under the Federal Food, Drug, and Cosmetic Act (FD&C Act), Sections 801 and 331. Repatha sold in Canada or the European Union carries different labeling than the FDA-approved version and is therefore technically an "unapproved drug" for U.S. Purposes. [1]

The FDA published a personal importation policy that outlines circumstances under which enforcement discretion may be exercised. The agency will generally not pursue action when all of the following conditions are met: the drug is for a serious condition, no effective domestic alternative exists, the quantity is a 90-day supply or less, the drug poses no unreasonable safety risk, the patient provides written confirmation it is for personal use, and the patient's physician accompanies or provides a statement. [2]

The 90-Day Supply Rule in Practice

Ninety days of Repatha at standard dosing (140 mg every two weeks or 420 mg monthly) means either 6 auto-injectors at 140 mg or 3 monthly prefilled cartridges at 420 mg. Customs officers at U.S. Ports of entry are not pharmacists. In practice, packages containing a single 90-day allotment shipped directly to a U.S. Address from a Canadian licensed pharmacy are rarely seized, but the FDA's discretion is not a right. It can be withdrawn at any time.

What Counts as a Violation

Purchasing more than a 90-day supply, reselling even a single injector, importing from an unlicensed or online-only pharmacy, or repeatedly importing the same drug on a rolling basis all move the transaction outside FDA's discretionary zone. U.S. Customs and Border Protection (CBP) has authority under 19 U.S.C. 1595a to seize merchandise imported contrary to law. [3]

How Much Cheaper Is Repatha Abroad?

Price differences are real and significant. Amgen sets country-specific prices based on each government's negotiating power, insurance framework, and reimbursement rules.

Canada

In Canada, Repatha is sold through provincial drug benefit programs and private insurance. The public list price (IQVIA data widely cited in Canadian drug-pricing literature) sits near CAD $350-380 per month for the 140 mg every-two-weeks regimen. That translates to roughly USD $255-280 at a 0.73 exchange rate. Canadians with provincial coverage through programs like Ontario's OHIP+ or British Columbia's PharmaCare may pay far less out of pocket, but a foreign national purchasing without Canadian insurance pays full list. The savings versus U.S. List price ($650/month) are about 55-60%. [4]

United Kingdom and Europe

The National Health Service (NHS) negotiates a confidential net price. Patients who are not NHS-entitled cannot simply walk into a UK pharmacy and purchase Repatha at the NHS rate. EU member states operate similar closed reimbursement systems. An uninsured American traveling to Germany or France and expecting to buy Repatha at the state-reimbursed price will be disappointed: retail prices in European pharmacies for uninsured purchasers are often comparable to U.S. Prices or higher.

Mexico and Other Countries

Repatha is registered in Mexico by Amgen and dispensed through major pharmacy chains such as Farmacias del Ahorro and Farmacias Guadalajara. Retail prices in Mexico City range from MXN $3,500-5,500 per month (approximately USD $180-285), making Mexico one of the more accessible cross-border options geographically for patients in the American Southwest. Cold-chain integrity during a border crossing in summer heat is a genuine concern.

Cold-Chain and Drug-Quality Risks When Importing

Repatha is a biologic. The prescribing information requires storage at 36-46 degrees Fahrenheit (2-8 degrees Celsius). [5] A single temperature excursion above 77 degrees Fahrenheit (25 degrees Celsius) for more than 30 days compromises the molecule. You cannot see, smell, or taste degradation in a monoclonal antibody.

The following framework helps patients evaluate cold-chain risk before any international purchase:

HealthRX Cold-Chain Risk Tier for Imported Biologics

| Tier | Scenario | Risk Level | |------|----------|------------| | 1 | Licensed pharmacy ships overnight with validated cold pack to U.S. Address, tracking confirms <24 hours transit | Low | | 2 | Patient hand-carries in insulated bag, border crossing under 4 hours, arrives refrigerated | Moderate | | 3 | Standard international mail, no temperature monitoring, summer months | High | | 4 | Third-party reseller, no cold-chain documentation | Unacceptable |

The WHO estimates that 10.5% of medical products in low- and middle-income countries are substandard or falsified, with biologics disproportionately represented. [6] Canada and Western Europe maintain quality standards similar to the U.S., but rogue online pharmacies, wherever nominally based, are a different matter.

Verifying a Foreign Pharmacy Is Legitimate

Canadian Pharmacies

Canada's regulatory body for pharmacy is the provincial college system. In British Columbia, the College of Pharmacists of BC maintains a public licensee directory. Ontario's equivalent is the Ontario College of Pharmacists. The Canadian International Pharmacy Association (CIPA) at cipa.com maintains a verified list of member pharmacies that meet Canadian regulatory standards. If a Canadian pharmacy is not a CIPA member and not listed with a provincial college, do not order from it.

The National Association of Boards of Pharmacy (NABP) publishes a "Not Recommended" list of online pharmacy websites. Before ordering, search the pharmacy name at nabp.pharmacy. NABP has flagged thousands of sites claiming Canadian registration that are actually operating from Eastern Europe or Southeast Asia.

Red Flags for Counterfeit Pharmacies

Any pharmacy that sells prescription drugs without requiring a valid prescription is operating outside the law in both the U.S. And Canada. Repatha requires a prescription in every country where it is approved. A site that skips prescription verification is a site that likely ships falsified product.

Legitimate Ways to Reduce Repatha Costs Without Importing

Patients and clinicians sometimes overlook domestic options that bring the out-of-pocket cost below what importation would achieve, with zero legal exposure.

Amgen's NEXT Program (Patient Assistance)

Amgen operates the Repatha NEXT program for commercially insured patients. Eligible patients may pay as little as $0 per month with a co-pay card. The program covers patients whose insurance covers Repatha but with a high co-pay. Enrollment is at amgensupportplus.com. Income caps and insurance-type exclusions apply; Medicare Part D and Medicaid beneficiaries are not eligible for the co-pay card but may qualify for the separate Amgen Safety Net Foundation free-drug program.

As Dr. Jennifer G. Robinson, a cardiologist and lipidologist at the University of Iowa, stated in the 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies: "The cost of PCSK9 inhibitors remains the primary barrier to use despite strong cardiovascular outcome data, and clinicians should systematically connect patients with manufacturer assistance programs before concluding that the drug is inaccessible." [7]

Insurance Prior Authorization Strategies

Most commercial insurers and Medicare Advantage plans require prior authorization (PA) for Repatha. PA approval rates increase substantially when the submitting physician documents: an LDL-C at or above 70 mg/dL on maximally tolerated statin therapy, a confirmed history of ASCVD (atherosclerotic cardiovascular disease) or heterozygous familial hypercholesterolemia (HeFH), and a 10-year ASCVD risk above 7.5% per the Pooled Cohort Equations. [8] The 2022 ACC/AHA Cholesterol Guideline recommends PCSK9 inhibitors for patients with clinical ASCVD and LDL-C persistently at or above 70 mg/dL despite maximally tolerated statins. [9] Documenting these data points in the PA letter dramatically shortens the approval timeline.

GoodRx and Discount Programs

GoodRx prices for Repatha at major U.S. Retail pharmacies range from $420-$520 per month as of late 2024, still high, but lower than list. GoodRx cannot be combined with insurance and is incompatible with the Amgen co-pay card. Patients should calculate both pathways: (insurance co-pay minus Amgen card) vs. GoodRx cash price.

Biosimilars

The first PCSK9 inhibitor biosimilar approved by the FDA was Releuko (bevacizumab-adcd), that is a different drug class. For evolocumab specifically, no FDA-approved biosimilar was on the U.S. Market as of January 2025, though Amgen's exclusivity on evolocumab expired in 2022 in Europe, where biosimilar applications are under review. The FDA's biosimilar pipeline for PCSK9 inhibitors will likely change this field within 24-36 months. [10]

The Clinical Evidence Behind Repatha: Why Patients Fight for Access

Understanding why patients pursue international purchase at all requires context: the cardiovascular benefit of evolocumab is among the most replicated findings in lipid medicine.

FOURIER Trial

The FOURIER trial enrolled 27,564 patients with established atherosclerotic cardiovascular disease and LDL-C of 70 mg/dL or higher on statin therapy. Patients received evolocumab (140 mg every two weeks or 420 mg monthly) or placebo. At a median follow-up of 2.2 years, evolocumab reduced LDL-C by a mean of 59% from baseline and reduced the primary composite endpoint (cardiovascular death, MI, stroke, unstable angina hospitalization, or coronary revascularization) by 15% vs. Placebo (hazard ratio 0.85; 95% CI 0.79-0.92; P<0.001). [11]

GLAGOV Trial

The GLAGOV trial (N=968) examined atherosclerosis progression by intravascular ultrasound (IVUS). Patients receiving evolocumab showed a mean 0.95% reduction in percent atheroma volume vs. A 0.05% increase in the placebo group (P<0.001). These imaging data demonstrate that LDL lowering with evolocumab produces measurable plaque regression, not just lipid-level changes. [12]

The 2019 ESC/EAS Guidelines for the Management of Dyslipidemias state: "PCSK9 inhibitors are recommended in very high-risk patients not reaching their LDL-C goals with maximum tolerated doses of statins and ezetimibe (Class I, Level A evidence)." [13]

What Happens If Your Repatha Is Seized at Customs?

If U.S. Customs seizes an imported shipment of Repatha, the patient receives a seizure notice. They have the option to contest the seizure in writing, demonstrating the 90-day personal-use conditions were met. In practice, most seized packages are simply retained; criminal prosecution of individual patients for a single 90-day importation is essentially unheard of. However, repeatedly importing, particularly from the same pharmacy, at high volume, or without a physician's documentation, increases exposure.

The FDA's Office of Criminal Investigations focuses its resources on commercial importers, counterfeit distributors, and physicians who prescribe across state or international lines without proper licensure. A patient obtaining a personal supply for a legitimate cardiovascular indication is at the lowest tier of enforcement priority. That remains an enforcement judgment, not a legal right.

Tax-Advantaged Accounts: HSA and FSA for Repatha

Repatha is a prescription drug and qualifies as a medical expense under IRS Publication 502. Health Savings Account (HSA) and Flexible Spending Account (FSA) funds can be used to pay for Repatha prescriptions filled at a U.S. Pharmacy. [14]

Critically, HSA/FSA funds cannot be used to reimburse purchases from foreign pharmacies that do not issue U.S.-standard receipts, because the expense may not be verifiable as a qualified medical expense under IRS rules. Some plan administrators require that prescriptions be filled at a pharmacy with a U.S. DEA or NABP registration. Check with your plan before submitting a reimbursement claim for an international purchase.

The annual HSA contribution limit for 2025 is $4,300 for self-only coverage and $8,550 for family coverage (IRS Rev. Proc. 2024-25). [15] At $520/month, a patient paying cash for Repatha without insurance can fully exhaust their HSA by October on that single medication alone.

A Step-by-Step Decision Path for Patients Considering International Purchase

Before contacting a foreign pharmacy, a patient should work through this sequence:

1. Confirm with their prescribing physician that Repatha is the appropriate drug (ruling out ezetimibe add-on as a lower-cost first step).
2. Submit a prior authorization request through their insurer, with full ASCVD documentation.
3. If PA is denied, file a formal appeal citing the ACC/AHA 2022 Cholesterol Guideline Class IIa recommendation.
4. Enroll in the Amgen NEXT co-pay program if commercially insured.
5. If Medicare Part D, apply to the Amgen Safety Net Foundation.
6. Price GoodRx at local pharmacies as a cash-pay fallback.
7. Only after exhausting steps 1-6 should international purchase be considered, and only from a CIPA-verified Canadian pharmacy with documented cold-chain shipping.

At step 7, the patient should bring documentation of their U.S. Prescription to present to the Canadian pharmacy (many CIPA members accept U.S. Prescriptions or coordinate with a Canadian prescriber), ship no more than a 90-day supply at a time, and retain all receipts and tracking information.